<DOC>
	<DOC>NCT02598817</DOC>
	<brief_summary>The purpose of this present study is to describe the acceptability and gastrointestinal tolerance of "High-sn-2" infant formula in non-breast fed healthy term infants in the Middle East by parent-reported outcome measures and pediatrician reported outcomes.</brief_summary>
	<brief_title>Acceptability and Gastrointestinal Tolerance of a High-Sn-2 Infant Formula</brief_title>
	<detailed_description>An open-label observational trial with a convenience sample of one hundred formula-fed infants recruited from a network of general pediatricians in the Middle Eastern countries of UAE, Kuwait, and Qatar. Eligible infants will consume a high SN-2 formula for 12 weeks. All enrolled infants will be evaluated at enrollment and at 4 weeks and 2 weeks.</detailed_description>
	<criteria>Health full term infants who are formula fed Partially breast and formula fed infants who drink at least 2 formula feedings per day; each to be at least 30 ml Age at time of enrollment: 2 weeks of age to 4 months of age Preterm or IUGR babies Contraindication of standard infant formula Cow's milk protein allergy Serious medical or surgical GI disease Multiple congenital anomalies Parents refusal to participate in the study Exclusive Breast fed babies</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>4 Months</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>